A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 10, 2009, Pages 2204-2216

  Cecchi, Cristina ^a   Nichino, Daniela ^a,b   Zampagni, Mariagioia ^a   Bernacchioni, Caterina ^a   Evangelisti, Elisa ^a   Pensalfini, Anna ^a   Liguri, Gianfranco ^a   Gliozzi, Alessandra ^a,b   Stefani, Massimo ^a   Relini, Annalisa ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

ADDLs; ADDLs GM1 colocalization; Alzheimer's disease; Amyloid induced membrane damage; Lipid raft cholesterol

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CHOLESTEROL; FLOTILLIN 1; MONOSIALOGANGLIOSIDE; MONOSIALOTETRAHEXOSYLGANGLIOSIDE; UNCLASSIFIED DRUG;

ANISOTROPY; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL MEMBRANE; CELL SURFACE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LIPID RAFT; MEMBRANE BINDING; MEMBRANE DAMAGE; MEMBRANE STRUCTURE; NEUROBLASTOMA CELL; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION;

AMYLOID BETA-PROTEIN; CELL SURVIVAL; CHOLESTEROL; HUMANS; MEMBRANE MICRODOMAINS; MICROSCOPY, ATOMIC FORCE; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 70349481147     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.07.019     Document Type: Article

References (68)

1. Walsh D.M., Klyubin I., Fadeeva J.Y., Callen W.K., Anvyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
2. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., and Ashe K.H. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat. Neurosci. 8 (2005) 79-84
3. Lesné S., Koh M.T., Kotlinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., and Ashe H. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
4. Selkoe D.J. Folding proteins in fatal ways. Nature 426 (2003) 900-904
5. Walsh D.M., and Selkoe D.J. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Peptide Lett. 11 (2004) 1-16
6. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amylopid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
7. Cecchi C., Rosati F., Pensalfini A., Formigli L., Nosi D., Liguri G., Dichiara F., Morello M., Danza G., Pieraccini G., Peri A., Serio M., and Stefani M. Seladin-1/dhcr24 protects neuroblastoma cells against abeta toxicity by increasing membrane cholesterol content. J. Cell. Mol. Med. 12 (2008) 1990-2002
8. Bokvist M., Lindström F., Watts A., and Gröbner G. Two types of Alzheimer's β-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J. Mol. Biol. 335 (2004) 1039-1049
9. Deshpande A., Mina E., Glabe C., and Busciglio J. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J. Neurosci. 26 (2006) 6011-6018
10. Bhatia H.R., Lin, and Lal R. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity. FASEB J. 14 (2000) 1233-1243
11. Stefani M., and Dobson C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81 (2003) 678-699
12. Kayed R., Sokolov Y., Edmonds B., McIntire T.M., Milton S.C., Hall J.E., and Glabe C.G. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279 (2004) 46363-46366
13. Demuro A., Mina E., Kayed R., Milton S., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280 (2005) 17294-17300
14. Kayed R., Pensalfini A., Margol L., Sokolov Y., Sarsoza F., Head E., Hall J., and Glabe C. Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J. Biol. Chem. 284 (2009) 4230-4237
15. Allen J.A., Halverson-Tamboli R.A., and Rasenick M.M. Lipid raft microdomains and neurotransmitter signalling. Nat. Neurosci. 8 (2007) 128-140
16. Morgan M.J., Kim Y.-S., and Liu Z. Lipid rafts and oxidative stress-induced cell death. Antiox. Redox Signal. 9 (2007) 1471-1483
17. Kusumi A., and Suzuki K. Toward understanding the dynamics of membrane raft-based molecular interactions. Biochim. Biophys. Acta 1746 (2005) 234-251
18. Crameri A., Biondi E., Kuehnle K., Lütjohann D., Thelen K.M., Perga S., Dotti C.G., Nitsch R.M., Ledesma M.D., and Mohajeri M.H. The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO J. 25 (2006) 432-443
19. Hattori C., Asai M., Onishi H., Sasagawa N., Hashimoto Y., Saido T.C., Marayama K., Mizutani S., and Ishiura S. BACE1 interacts with lipid raft proteins. J. Neurosci. Res. 84 (2006) 912-917
20. Vetrivel K.S., Cheng H., Lin W., Sakurai T., Li T., Nukina N., Wong P.C., XU H., and Thinakaran G. Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J. Biol. Chem. 279 (2004) 44945-44954
21. Yoon I.S., Chen E., Busse T., Repetto E., Lakshmana M.K., Koo E.H., and Kang D.E. Low-density lipoprotein receptor-related protein promotes amyloid precursor protein trafficking to lipid rafts in the endocytic pathway. FASEB J. 21 (2007) 2742-2752
22. Taylor D.R., and Hooper N.M. The prion protein and lipid rafts. Mol. Membr. Biol. 23 (2006) 89-99
23. Prusiner S.B., Scott M.R., DeArmond S.J., and Cohen F.E. Prion Protein Biology. Cell 93 (1998) 337-348
24. Harris D.A. Cellular biology of prion diseases. Clin. Microbiol. Rev. 12 (1999) 429-444
25. c association with lipid rafts in the early secretory pathway stabilizes its cellular conformation. Mol. Biol. Cell. 15 (2004) 4031-4042
26. Ehehalt R., Keller P., Haass C., Thiele C., and Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160 (2003) 113-123
27. Kakio A., Nishimoto S., Kozutsumi Y., and Matsuzaki K. Formation of a membrane-active form of amyloid beta-protein in raft-like model membranes. Biochem. Biophys. Res. Commun. 303 (2003) 514-518
28. Suzuki T., Ito J., Takagi H., Saitoh F., Nawa H., and Shimizu H. Biochemical evidence for localization of AMPA-type glutamate receptor subunits in the dendritic raft. Brain Res. Mol. Brain Res. 89 (2001) 20-28
29. Besshoh S., Bawa D., Teves L., Wallace M.C., and Gund J.W. Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post-synaptic densities following transient global ischemia in the rat brain. J. Neurochem. 93 (2005) 186-194
30. Hsieh H., Boehm J., Sato C., Iwatsubo T., Tomita T., Sisodia S., and Malinow R. AMPAR removal underlies Aβ-induced synaptic depression and dendritic spine loss. Neuron. 52 (2006) 831-843
31. De Felice F.G., Velasco P.T., Lambert M.P., Viola K., Fernandez S.J., Ferreira S.T., and Klein W.L. Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Biol. Chem. 282 (2007) 11590-11601
32. Wu Y., Aral A.C., Rumbaugh G., Srivastava A.K., Turner G., Hayashi T., Suzuki E., Jiang Y., Zhang L., Rodriguez J., Boyle J., Tarpey P., Raymond F.L., Nevelsteen J., Froyen G., Stratton M., Futreal A., Gecz J., Stevenson R., Schwartz C.E., Valle D., Huganir R.L., and Wang T. Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 18163-18168
33. Kim S.I., Yi J.S., and Ko Y.G. Amyloid beta oligomerization is induced by brain lipid rafts. J. Cell. Biochem. 99 (2006) 1878-1889
34. Cordy J.M., Hussain I., Dingwall C., Hooper N.M., and Turner A.J. Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 11540-11573
35. Ehehalt R., Keller P., Haass C., Thiele C., and Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160 (2003) 113-123
36. Morishima-Kawashima M., and Ihara Y. The presence of amyloid beta protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. Biochemistry 37 (1998) 15247-15253
37. Saavedra L., Mohamed A., Ma V., Kar S., and Posese de Chaves E. Internalization of β-amyloid peptide by primary neurons in the absence of apolipoprotein. J. Biol. Chem. 282 (2007) 35722-35732
38. Chen T.Y., Liu P.H., Ruan C.T., Chiu L., and Kung F.L. The intracellular domain of amyloid precursor protein interacts with flotilin-1, a lipid raft protein. Biochem. Biophys. Res. Commun. 342 (2006) 266-272
39. Williamson R., Usardi A., Hanger D.P., and Anderton B.H. Membrane-bound β-amyloid oligomers are recruited into lipid rafts by a Fyn-dependent mechanism. FASEB J. 22 (2008) 1552-1559
40. Ledesma M.D., and Dotti C.G. The conflicting role of brain cholesterol in Alzheimer's disease: lessons from the brain plasminogen system. Biochem. Soc. Symp. 72 (2005) 129-138
41. Arispe N., and Doh M. Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease Abeta(1-40) and (1-42) peptides. FASEB J. 16 (2002) 1526-1536
42. Lambert M.P., Viola K.L., Chromy B.A., Chang L., Morgan T.E., Yu J., Venton D.L., Krafft G.A., Finch C.E., and Klein W.L. Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies. J. Neurochem. 79 (2001) 595-605
43. Amundson D.M., and Zhou M. Fluorometric method for the enzymatic determination of cholesterol. J. Biochem. Biophys. Methods 38 (1999) 43-52
44. 2 release from activated human leukocytes using a dihydroxyphenoxazine derivative. J. Immunol. Methods 202 (1997) 133-141
45. Hojjati M.R., and Jiang X. Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine. J. Lipid. Res. 47 (2006) 673-676
46. Relini A., Cavalleri O., Canale C., Svaldo-Lanero T., Rolandi R., and Gliozzi A. What can atomic force microscopy say about amyloid aggregates?. In: Bushan B., Fuchs H., and Tomitori M. (Eds). Applied Scanning Probe Methods IX - Characterization (2008), Springer Verlag, Heidelberg 177-206 cap. 20
47. Simakova O., and Arispe N.J. The cell-selective neurotoxicity of the Alzheimer's Abeta peptide is determined by surface phosphatidylserine and cytosolic ATP levels. Membrane binding is required for Abeta toxicity. J. Neurosci. 27 (2007) 13719-13729
48. Rasband W.S. ImageJ, U. S. National Institutes of Health (1997-2008), Bethesda, Maryland, USA. http://rsb.info.nih.gov/ij/ http://rsb.info.nih.gov/ij/
49. Bradford M.M. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
50. Romiti E., Meacci E., Tanzi G., Becciolini L., Mitsutake S., Farnararo M., Ito M., and Bruni P. Localization of neutral ceramidase in caveolin-enriched light membranes of murine endothelial cells. FEBS Lett. 506 (2001) 163-168
51. Cecchi C., Baglioni S., Fiorillo C., Pensalfini A., Liguri G., Nosi D., Rigacci S., Bucciantini M., and Stefani M. Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates. J. Cell Sci. 118 (2005) 3459-3470
52. Cecchi C., Pensalfini A., Stefani M., Baglioni S., Fiorillo C., Cappadona S., Caporale R., Nosi D., Ruggiero M., and Liguri G. Replicating neuroblastoma cells in different cell cycle phases display different vulnerability to amyloid toxicity. J. Mol. Med. 86 (2008) 197-209
53. Wood W.G., Schroeder F., Avdulov N.A., Chochina S.V., and Igbavboa U. Recent advances in brain cholesterol dynamics: transport, domains and Alzheimer's disease. Lipids 34 (1999) 225-234
54. Shinitzky M., and Barenholz Y. Dynamics of the hydrocarbon layer in liposomes of lecithin and sphingomyelin containing dicetylphosphate. J. Biol. Chem. 249 (1974) 2652-2657
55. Lentz B.R. Membrane "fluidity" as detected by diphenylhexatriene probes. Chem. Phys. Lipids 50 (1989) 171-190
56. Canale C., Torrassa S., Rispoli P., Relini A., Rolandi R., Bucciantini M., Stefani M., and Gliozzi A. Natively folded HypF-N and its early amyloid aggregates interact with phospholipid monolayers and destabilize supported phospholipid bilayers. Biophys. J. 91 (2006) 4575-4588
57. Egawa H., and Furusawa K. Liposome adhesion on mica surface studied by atomic force microscopy. Langmuir 15 (1999) 1660-1666
58. Leonenko Z., Finot E., and Cramb D. AFM study of interaction forces in supported planar DPPC bilayers in the presence of general anesthetic halothane. Biochim. Biophys. Acta 1758 (2006) 487-492
59. Yip C.M., Elton E.A., Darabie A.A., Morrison M.R., and McLaurin J. Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity. J. Mol. Biol. 311 (2001) 723-734
60. Kawahara M., Kuroda Y., Arispe N., and Rojas E. Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J. Biol. Chem. 275 (2000) 14077-14083
61. Yanagisawa K. Role of gangliosides in Alzheimer's disease. Biochim. Biophys. Acta 1768 (2007) 1943-1951
62. Fujita A., Cheng J., Hirakawa M., Furukawa K., Kusunoki S., and Fujimoto T. Gangliosides GM1 and GM3 in the living cell membrane form clusters susceptible to cholesterol depletion and chilling. Mol. Biol. Cell. 18 (2007) 2112-2122
63. Lentz B.R. Use of fluorescent probes to monitor molecular order and motions within liposome bilayers. Chem. Phys. Lipids 64 (1993) 99-116
64. Companyó M., Iborra A., Villaverde J., Martínez P., and Morros A. Membrane fluidity changes in goat sperm induced by cholesterol depletion using beta-cyclodextrin. Biochim. Biophys. Acta 1768 (2007) 2246-2255
65. Kaiser R.D., and London E. Location of diphenylhexatriene (DPH) and its derivatives within membranes: comparison of different fluorescence quenching analyses of membrane depth. Biochemistry 37 (1998) 8180-8190
66. Eckert G.P., Wood W.G., and Müller W.E. Membrane disordering effects of beta-amyloid peptides. Subcell Biochem. 38 (2005) 319-337
67. Rinia H.A., Kik R.A., Demel R.A., Snel M.M.E., Killian J.A., van der Eerden J.P.J.M., and de Kruijff B. Visualization of highly ordered striated domains induced by transmembrane peptides in supported phosphatidylcholine bilayers. Biochemistry 39 (2000) 5852-5858
68. Teller H.W., Waring A.J., Lehrer R.I., Harroun T.A., Weiss T.M., Yang L., and Huang H.W. Membrane thinning effect of the β-sheet antimicrobial peptide protegrin. Biochemistry 39 (2000) 139-145